Physician profile
Anna Leigh Hronek
NPI 1538500731
$81,975.06
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2021: $12K · 2022: $23K · 2023: $21K · 2024: $9,887 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Travel and Lodging: $6,089 · Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,851.62 |
| Travel and Lodging | $6,088.57 |
| Food and Beverage | $1,629.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $81,402.82 | 2019-2025 | Truelok, G-Beam Fusion Beaming System, Fitbone |
| Mimedx Group, INC. | $189.48 | 2024 | |
| Integra Lifesciences Corporation | $93.03 | 2019 | |
| Smith+Nephew, INC. | $68.84 | 2019-2022 | |
| Solventum Corporation | $46.34 | 2024-2025 | Activ.A.C., Prevena |
| Medline Industries Lp | $42.45 | 2024 | |
| Stryker Corporation | $36.79 | 2023 | Prophecy |
| Triad Life Sciences INC. | $34.31 | 2022 | |
| Osiris Therapeutics INC. | $21.45 | 2019 | |
| Urgo Medical North America, LLC | $20.83 | 2025 | Urgoclean Ag |
| Melinta Therapeutics, LLC | $18.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hronek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.